PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Minnesota, Minneapolis, Minnesota, USA.\', \'Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Research Institute of the McGill University Health Centre and the Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec, Canada.\', \'Oregon Health and Science University, Portland, Oregon, USA.\', \'Section of Infectious Diseases, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.\', \'Hennepin Healthcare, Minneapolis, Minnesota, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1571
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33068425
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all